Successfully reported this slideshow.
We use your LinkedIn profile and activity data to personalize ads and to show you more relevant ads. You can change your ad preferences anytime.
Why Biosimilars superior to Biologics?
105 Pages
Report
Published Date: 18 March 2014Published Date : 07 April 2014
95 Pages
Report
Published Date: 08 April 2014...
Table of Content
1. Introduction
2. Executive Summary
3. Global 3D Technology Market Overview
4. Global 3D Technology Mark...
1. INTRODUCTION
2. EXECUTIVE SUMMARY
3. MARKET OVERVIEW
4. GLOBAL BIOSIMILARS/FOLLO-ON-BIOLOGICS MARKET BY TECHNOLOGY
5. G...
Description
Biosimilars or follow-on-biologics are the “copied” version of reference biologics,
which are protected by int...
The study is segmented in a strategic divisions to gain deeper insights into the market dynamics
and understand the compe...
Global Biosimilars Market Overview
Value chain
analysis
Global
Biosimilars
Market
OverviewPorters five
force
analysis
Mark...
Your feedback is important to us
What would you like to know more about this Study ?
 Global Industry Analysis
 Market S...
GLOBAL
BIOSIMILARS/FOL
LOW-ON-
BIOLOGICS
MARKET BY
APPLICATIONS
Blood disorders
Oncology diseases
Chronic and
autoimmune
d...
GLOBAL BIOSIMILARS/FOLLO-ON-BIOLOGICS MARKET BY
TECHNOLOGIES
Market
By
Technologies
Bioassay
Western Blotting
MASS SPECTRO...
GLOBAL BIOSIMILARS/FOLLO-ON-BIOLOGICS MARKET By ,
GEOGRAPHY
Top Market Players of Biosimilars/Follo-On-Biologics Market
 Novartis (Sandoz)
 Synthon Pharmaceuticals, Inc.
 Teva Pha...
Your feedback is important to us
What would you like to know more about this Study ?
 Global Industry Analysis
 Market S...
To View the Complete Report
Visit -
http://www.alliedmarketresearch.com/
biosimilars-market
Upcoming SlideShare
Loading in …5
×

Global biosimilars & follow on-biologics market (technology, types, applications, services and geography) - size, share, global trends, company profiles, demand, analysis, opportunities, segmentation and forecast, 2013 - 2020

1,275 views

Published on

Biosimilars or follow-on-biologics are the “copied” version of reference biologics, which are protected by intellectual rights that will expire soon. Patent expiration is the major driving factor of the biosimilars market.

Published in: Health & Medicine
  • Be the first to comment

  • Be the first to like this

Global biosimilars & follow on-biologics market (technology, types, applications, services and geography) - size, share, global trends, company profiles, demand, analysis, opportunities, segmentation and forecast, 2013 - 2020

  1. 1. Why Biosimilars superior to Biologics?
  2. 2. 105 Pages Report Published Date: 18 March 2014Published Date : 07 April 2014 95 Pages Report Published Date: 08 April 2014 108 Pages Report 86 Pages Report Published Date : 15 April 2014 112 Pages Report Published Date : 21 April 2014 145 Pages Report Published Date : 25 June 2014 114 Pages Report Published Date : 30 June 2014Published Date: 1 July 2014 140 Pages Report 184 Pages Report
  3. 3. Table of Content 1. Introduction 2. Executive Summary 3. Global 3D Technology Market Overview 4. Global 3D Technology Market by Products 5. Global 3D Technology Market by Applications 6. Global 3D Technology Market by Geography 7. Company Profiles Introduction Scope of the Report Key Benefits Key Audiences
  4. 4. 1. INTRODUCTION 2. EXECUTIVE SUMMARY 3. MARKET OVERVIEW 4. GLOBAL BIOSIMILARS/FOLLO-ON-BIOLOGICS MARKET BY TECHNOLOGY 5. GLOBAL BIOSIMILARS/FOLLOW-ON-BIOLOGICS MARKET BY PRODUCT TYPE 6. GLOBAL BIOSIMILARS/FOLLOW-ON-BIOLOGICS MARKET BY APPLICATIONS 7. GLOBAL BIOSIMILARS / FOLLOW-ON-BIOLOGICS MARKET BY SERVICES 8. GLOBAL BIOSIMILARS/FOLLOW-ON-BIOLOGICS MARKET BY GEOGRAPHIES 9. KEY PRODUCTS AND RECENT ACTIVITIES BY GEOGRAPHY 10 . COMPANY PROFILES Table of Contents
  5. 5. Description Biosimilars or follow-on-biologics are the “copied” version of reference biologics, which are protected by intellectual rights that will expire soon. Patent expiration is the major driving factor of the biosimilars market. Most of the blockbuster patents will expire by the end of 2014, which would provide a competitive edge to local pharmaceutical manufacturers over the global players. For instance, patents for insulin glargine will expire by the end of this year, which would give an opportunity for the growth of insulin biosimilars market. Global biosimilars/follow-on-biologics market accounted for $1,358 million in 2013 and it is anticipated to generate $35,032 million by 2020, growing at a CAGR of 60.8% from 2014 to 2020. Regulations for biosimilars plays a vital role in maintaining the viability and balance between original and biosimilar products. Various regulatory authorities, namely EMA and the U.S. FDA are actively regulating the biosimilars market. Regulations in the European union are considered benchmark around the world, as the guidelines proposed are most stringent for validation and commercialization of biosimilars. High profitability is the attractive aspect that is enticing companies to invest in the biosimilars industry.
  6. 6. The study is segmented in a strategic divisions to gain deeper insights into the market dynamics and understand the competitive environment of the overall market Financial market forecast is provided for the next eight years by considering 2013 as the base year Comprehensive and quantitative data about changing market trends, intensifying competition and opportunities in biosimilars market are provided to make better business decisions Porter’s Five Forces model and SWOT analysis of the overall market is provided to help stakeholders gain strategic insights of the market Deep dive analysis of key market players and strategies adopted by them are expounded to provide valuable information on the top contenders in the market Identification of key investment pockets for the biosimilars market is strategically dealt to assist the stakeholders KEY BENEFITS
  7. 7. Global Biosimilars Market Overview Value chain analysis Global Biosimilars Market OverviewPorters five force analysis Market Definition and Scope Diverse approach of global regulators towards biosimilars Key Findings Safety issues of biosimilar drugs Emerging economies a hotspot for biosimilars market Regulation & Reimbursement scenario
  8. 8. Your feedback is important to us What would you like to know more about this Study ?  Global Industry Analysis  Market Size  Market Share  Market Trends Opportunities and Forecast Please inform us on : http://www.alliedmarketresearch.com/contact-us Market Dynamics Key Market Drivers Market Restraints High cost of Production Market Dynamics Growing pressure to reduce healthcare expenditure Economic and scientific obstacles Medical Efficacy and Patient Safety Various blockbusters going off patent High prevalence of chronic diseases among population Lower cost biosimilars drugs than original biologics High initial investment in research and development
  9. 9. GLOBAL BIOSIMILARS/FOL LOW-ON- BIOLOGICS MARKET BY APPLICATIONS Blood disorders Oncology diseases Chronic and autoimmune diseases Growth hormone deficiency Others GLOBAL BIOSIMILARS/FOLLOW-ON-BIOLOGICS MARKET By APPLICATIONS
  10. 10. GLOBAL BIOSIMILARS/FOLLO-ON-BIOLOGICS MARKET BY TECHNOLOGIES Market By Technologies Bioassay Western Blotting MASS SPECTROMETRY Electrophoresis Nuclear magnetic resonance (NMR) technology Chromatography Recombinant DNA Technology Monoclonal Antibodies (MAb) Technology
  11. 11. GLOBAL BIOSIMILARS/FOLLO-ON-BIOLOGICS MARKET By , GEOGRAPHY
  12. 12. Top Market Players of Biosimilars/Follo-On-Biologics Market  Novartis (Sandoz)  Synthon Pharmaceuticals, Inc.  Teva Pharmaceutical Industries Ltd.  LG Life Sciences  Celltrion  Biocon  Hospira  Merck Serono (Merck Group)  Biogen idec Inc.  Genentech (Roche Group)
  13. 13. Your feedback is important to us What would you like to know more about this Study ?  Global Industry Analysis  Market Size  Market Share  Market Trends Opportunities and Forecast Please inform us on : http://www.alliedmarketresearch.com/contact-us
  14. 14. To View the Complete Report Visit - http://www.alliedmarketresearch.com/ biosimilars-market

×